| Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic | Murat TÖRÜNER,İsmail Hakkı KALKAN,Filiz AKYÜZ,Ahmet TEZEL,Aykut Ferhat ÇELİK | 488–492 |
| Clinical Scoring Systems in Predicting the Outcomes of Small Bowel Bleeding | Su SHUAİ,Zhang ZHİFANG,Wang YUMİNG,Jin HONG,Sun CHAO,Jiang KUİ,Wang BANGMAO | 493–499 |
| Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis | Masoumeh AZİMİRAD,Sara Mohammad Ali GOL,Ehsan JAVANMARD,Hamed MİRJALALİ,Abbas YADEGAR,Hamid Asadzadeh AGHDAEİ,Shabnam SHAHROKH,Amir SADEGHİ,Mohammad Reza ZALİ | 500–507 |
| Risk Factors for Vitamin D Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis | Shanzhen SHİ,Jiaxing FENG,Lixiang ZHOU,Yu Lİ,Huaxiu SHİ | 508–518 |
| Role of Endoscopic Ultrasound Elastography Strain Histograms in the Evaluation of Patients with Pancreatic Masses | Hussein Hassan OKASHA,Hussein EL-AMİN,Zain El-Abdeen SAYED,Ahmed Abd ElFadeel MAGHRABY | 519–525 |
| Evaluation of Validity and Efficiency of Diagnostic Criteria in Autoimmune Hepatitis in Children | Mohammadhadi IMANİEH,Nazanin Amin FARZANEH,Seyed Mohsen DEHGHANİ,Maryam Gholami SHAHREBABAK,Samaneh Hamzelou HOSSEİNABADİ | 526–531 |
| miR-224 Regulates the Aggressiveness of Hepatoma Cells Through the IL-6/STAT3/SMAD4 Pathway | Fangmei AN,Xiongbo WU,Yunan ZHANG,Dayang CHEN,Guoqiang ZHANG,Yexin LİN,Fang WU,Junli DİNG,Min XİA,Qiang ZHAN | 532–542 |
| Ulcerative Colitis in a COVID-19 Patient: A Case Report | Muhammet Fatih AYDIN,Hamit TAŞDEMİR | 543–547 |